TITAN Metal Fabricators acquired select assets of Edge International, distributor of raw materials used in the manufacture of implants and instruments for the orthopaedic, spine and trauma markets.
Oxford Finance closed a US $20MM senior secured term loan with Cerapedics. Proceeds will support commercialization of i-FACTOR bone graft for ACDF and fund an FDA study on its application in TLIF.
Six-year study results on the treatment of SI joint disorders indicated that treatment with conservative management or radiofrequency denervation led to worsened outcomes, while iFuse Implant patients demonstrated superior improvements.